CRISPR enhances cancer immunotherapy

CRISPR enhances cancer immunotherapy

Scientists at the School of Medicine have used the gene-editing technology CRISPR to engineer human T cells that can attack human T cell cancers without succumbing to friendly fire. The study evaluating the approach in mice appears online in the journal Leukemia.
Developing enabling technology for emerging gene therapies

Developing enabling technology for emerging gene therapies

For years, researchers have attempted to harness the full potential of gene therapy, a technique that inserts genes into a patient’s cells to treat cancer and other diseases. However, inserting engineered DNA molecules into cells is difficult. A team of engineers at Washington University in St. Louis has developed a new method that could make the process easier.
Similarities found in cancer initiation in kidney, liver, stomach, pancreas

Similarities found in cancer initiation in kidney, liver, stomach, pancreas

School of Medicine researchers have found that when mature cells transition to begin dividing again, they all seem to do it the same way, regardless of what organ those cells come from. These older cells may be dangerous because when they revert to stem cell-like behavior, they carry with them all the potential cancer-causing mutations that have accumulated during their lifespans.
Older Stories